The global blood gas and electrolyte analyzer market size is expected to reach USD 3.71 billion by 2030, registering a CAGR of 4.5%, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.
Request a free sample copy or view report summary: Blood Gas And Electrolyte Analyzer Market Report
Consumables dominated the market with a revenue share of 66.28% in 2023 and is anticipated to grow at the fastest growth rate over the forecast period, driven by their increasing demand.
Clinical laboratory dominated the market with a revenue market share of 46.98% in 2023. In the rapidly advancing landscape of healthcare technology, Blood Gas Analyzers (BGAs) have become indispensable for clinical laboratories, offering real-time insights into a patient's respiratory and metabolic status.
North America accounted for 42.22% of the blood gas and electrolyte analyzers market in 2023. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.
Grand View Research has segmented the global blood gas and electrolyte analyzer market based on product, end-use, and region:
Blood Gas And Electrolyte Analyzer Product Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Instrument, by Type
Bench Top
Portable
Instrument, by Brand
I-STAT
epoc
GEM Premier (3500& 5000)
ABL Flex (90 and 800)
Cobas
RAPID Series
Others
Consumables
Blood Gas And Electrolyte Analyzer End Use Outlook (Revenue, USD Million, 2018 - 2030)
Clinical Laboratory
Point-of-care
Diagnostic Centers
Others
Blood Gas And Electrolyte Analyzer Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Singapore
Malaysia
Indonesia
Thailand
Vietnam
Philippines
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Blood Gas And Electrolyte Analyzer Market
Abbott
Meizhou Cornley High-Tech Co., Ltd.
Radiometer Medical ApS
EDAN Instruments, Inc.
Erba Mannheim
F. Hoffmann-La Roche Ltd
Fortress Diagnostics
Werfen
LifeHealth
Medica Corporation
OPTI Medical Systems, Inc.
Sensa Core
Siemens Healthineers AG
"The quality of research they have done for us has been excellent..."